Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, nomegestrol acetate/estradiol (Zoely®) cannot be endorsed for use within NHS Wales for oral contraception. |
||
|
||
Medicine details |
||
| Medicine name | nomegestrol acetate/estradiol (Zoely®) | |
| Formulation | 2.5 mg/1.5 mg film-coated tablet | |
| Reference number | 1050 | |
| Indication | For use within NHS Wales for oral contraception. |
|
| Company | Merck Sharp & Dohme Ltd | |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | 22/12/2011 | |
| Date of issue | 06/01/2012 | |